ga101
Showing 1 - 6 of 6
Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)
Active, not recruiting
- Chronic Lymphocytic Leucemia
- Bendamustine
- +2 more
-
Cologne, GermanyGerman CLL Study Group
Sep 14, 2022
Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, CAL-101)
Active, not recruiting
- Chronic Lymphocytic Leucemia
- Bendamustine
- +2 more
-
Cologne, GermanyGerman CLL Study Group
Apr 29, 2022
CD20 Positive Diffuse Large B-cell Lymphoma, Elderly Unfit Patients Trial in Italy (Ga101)
Terminated
- CD20 Positive Diffuse Large B-cell Lymphoma
- Elderly Unfit Patients
- Ga101
-
Brescia, BS, Italy
- +15 more
Nov 4, 2020
Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, Ibrutinib)
Completed
- Chronic Lymphocytic Leucemia
- Bendamustine
- +2 more
-
Cologne, GermanyGerman CLL Study Group
May 7, 2019
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Tours (GA101, Ibrutinib, Cyclophosphamide)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- GA101
- +3 more
-
Tours, FranceSponsor FILO
Feb 14, 2019
Diffuse Large B Cell Lymphoma CD20 Positive Trial in Belgium, France (GA101, Rituximab, Doxorubicin)
Terminated
- Diffuse Large B Cell Lymphoma CD20 Positive
- GA101
- +7 more
-
Antwerpen, Belgium
- +121 more
Mar 6, 2018